Recent news coverage focuses on Phreesia's Q1 2027 earnings results, including transcripts and analyses of key financial metrics and revenue performance.

• Phreesia reported Q1 2027 earnings with revenue of $130.9 million and net income of $2.96 million, reflecting profitability in the quarter [N1].
• Analyses of Q1 earnings highlighted key metrics and revenue performance across subscription, payment solutions, and Network Solutions segments [N2].
• Coverage noted that Phreesia's Q1 earnings and revenues exceeded expectations, indicating operational progress [N3].
• Discussions around Q1 earnings included insights into Wall Street projections and key financial indicators [N4].
• Market reactions to Phreesia stock were analyzed in the context of recent earnings and operational developments [N5].

Phreesia's integrated platform addresses critical healthcare delivery challenges with a diversified revenue model anchored in recurring fees, supporting revenue visibility. The acquisition of AccessOne expands payment capabilities, potentially enhancing cash flow acceleration for providers. The company's scale, interoperability, and compliance focus may support competitive positioning. Incorporation of AI into solutions could improve operational efficiency and client value. Recent quarterly profitability and liquidity improvements, including refinancing of credit facilities, indicate financial progress. The company's broad customer base and platform usage suggest potential for continued adoption and expansion.

Phreesia operates in a highly competitive and rapidly evolving healthcare technology market, facing competition from established and emerging AI-enabled solutions. The company depends on third-party suppliers and contract manufacturers for hardware components, which may pose supply chain risks. Regulatory and privacy compliance requirements are complex and evolving, with potential for enforcement actions or increased costs. Sales cycles can be lengthy, and the company may face challenges in managing growth and maintaining customer retention. Market adoption of its solutions depends on demonstrating clear value to clients and patients, which may vary. Financial performance may be affected by these operational and regulatory risks.

Phreesia's competitive strengths include its broad and integrated platform addressing multiple healthcare delivery challenges, extensive provider and patient network scale, interoperability with major electronic medical record and practice management systems, and a compliance-first engagement model. The company's recurring revenue streams and diversified offerings across subscription, payment, and network solutions provide revenue visibility. Its certifications and comprehensive privacy and security programs support trust and regulatory compliance. The integration of AI into its platform enhances automation and personalization, potentially differentiating its solutions. However, competition from established vendors and new entrants incorporating AI remains significant.

• Competition and Market Dynamics: Phreesia faces competition from established vendors and new entrants incorporating AI, which may increase competitive pressure and affect market share and profitability.
• Regulatory and Privacy Compliance: The company operates under complex and evolving federal and state healthcare, data privacy, and telecommunications laws, including HIPAA and CCPA/CPRA, with risks of enforcement actions and penalties for non-compliance.
• Supply Chain and Third-Party Dependencies: Phreesia relies on third-party suppliers and contract manufacturers for hardware components; disruptions or inability to secure materials at reasonable costs could adversely affect operations.
• Sales Cycle and Customer Retention: Sales cycles vary by customer size and complexity, with some contracts requiring annual renewal; failure to retain customers or delays in contract renewals could impact revenue.
• Operational and Financial Risks: The company may incur net losses in the future despite recent profitability; managing growth, investments, and liquidity are ongoing challenges.

• Phreesia, Inc. provides an integrated software, payments, and engagement platform addressing access to care, affordability, and patient health outcomes in healthcare delivery [S1].
• The platform is embedded into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum [S1].
• Phreesia serves ambulatory practices, health systems, hospitals, life sciences companies, government entities, patient advocacy groups, public interest, and not-for-profit organizations [S1].
• The platform supports the patient journey from care discovery and scheduling through intake, payment, and post-visit follow-up [S1].
• In fiscal year 2026, Phreesia's platform facilitated approximately 180 million patient visits, representing about one in six ambulatory patient visits in the U.S. [S1].
• Phreesia completed the acquisition of AccessOne Parent Holdings, Inc. in fiscal 2026, expanding its addressable market for healthcare payments and offering a healthcare payment card solution [S1].
• Revenue is generated through three streams: subscription and related services; payment solutions (including payment processing and financing fees); and Network Solutions for life sciences and other organizations to engage patients and providers [S1].
• Revenue is primarily recurring, with subscription and related services revenue relatively consistent throughout the fiscal year, payment solutions revenue typically higher early in the calendar year, and Network Solutions revenue higher in the second half of the fiscal year [S1].
• Phreesia's platform capabilities include care discovery and scheduling, appointment optimization, referral management, AI-enabled patient communications, eligibility and cost transparency tools, integrated payment and financing solutions, digital intake, clinical data capture, patient engagement tools, and analytics [S1].
• The company estimates its total addressable market at approximately $24 billion, including subscription services, payment-related fees, and Network Solutions revenue [S1].
• Phreesia's platform is built on a scalable, cloud-enabled architecture supporting healthcare interoperability, security, and regulatory compliance, integrating with major electronic medical record and practice management systems [S1].
• Artificial intelligence is increasingly incorporated into Phreesia's solutions for automation, personalization, analytics, and operational efficiency [S1].
• Phreesia maintains comprehensive privacy and security programs, including certifications such as HITRUST, PCI-DSS Level 1 Service Provider, SOC 2, and PCI Point-to-Point Encryption, to safeguard client and patient data [S1].
• Sales and marketing are conducted via a direct sales organization with dedicated teams for healthcare services and Network Solutions clients, focusing on maximizing total customer enterprise value and land-and-expand growth [S1].
• Most healthcare services contracts are annual, auto-renewing agreements; Network Solutions contracts are typically one-year terms aligned with life sciences marketing budget cycles [S1].
• Phreesia operates in a competitive healthcare technology market with competition from established vendors and new entrants incorporating AI; the company competes on platform breadth, interoperability, scale, compliance, and measurable value [S1].
• Phreesia is subject to extensive and evolving federal and state healthcare, data privacy, security, and telecommunications laws and regulations, including HIPAA, FTC regulations, TCPA, and state privacy laws such as CCPA/CPRA [S1].
• The company is a HIPAA business associate and must comply with breach notification rules and other privacy and security requirements, with potential civil and criminal penalties for violations [S1].
• Phreesia's fiscal year ends January 31; the latest quarterly financials are for the period ended April 30, 2026 [S2].
• For the quarter ended April 30, 2026, Phreesia reported total revenue of $130.9 million, net income of $2.96 million, and basic and diluted EPS of $0.05 [S2].
• Revenue breakdown for Q1 2027: subscription and related services $52.7 million, payment solutions $41.9 million, Network Solutions $36.3 million [S2].
• Operating income for Q1 2027 was $6.75 million, with total expenses of $124.2 million [S2].
• Phreesia had cash and cash equivalents of $73.8 million as of January 31, 2026, and $76.4 million as of April 30, 2026 [S1, S2].
• Current assets as of April 30, 2026 were $267.3 million; current liabilities were $152.1 million, yielding a current ratio of 1.76 and a cash ratio of 0.49 [S2].
• Phreesia completed a refinancing in March 2026, replacing a bridge loan with a new $275 million senior secured revolving credit facility maturing in 2031 [S1, S2].
• The company had 63.2 million shares issued as of April 30, 2026 [S2].
• Phreesia's business model provides meaningful visibility into future revenue due to the recurring nature of subscription and payment processing fees [S1].
• Recent news coverage includes detailed Q1 2027 earnings transcripts and analyses of key metrics and revenue performance [N1, N2, N3, N4].